Among the genes listed as peripheral surrogate marker candidates (Supplemental Table 20), three genes, PER1, FKBP5, and SLC16A1 were up- or down-regulated significantly in the peripheral blood data sets from MS patients, although these data sets were from small numbers of patients with unknown clinical histories (Supplemental Table 21). Here, SLC16A1 is linked to myeloid sarcoma.